Noticias

March 5,2007  Janauary 9, 2007 August 1, 2006 February 1, 2006	BurnsAdler Partners with X-GEN to return Colistimethate for Injection to the Mexican Market BurnsAdler and Serral Enter into a Promotional Agreement BurnsAdler Licenses Gentamicin Surgical Implant from Innocoll New Promotion Agreement with Sigma-Tau
November 8, 2005	Nitronal® Infusion Approved for Sale in Mexico
February 18, 2005	BurnsAdler Partners with Sigma-Tau S.p.A. to Promote Natulan®
February 9, 2005	BurnsAdler Partners to Expand Puerto Rico Franchise
September 7, 2004	Giancarlo Mennella, M.D. Named to Advisory Board
March 5, 2004	BurnsAdler Licenses Anti-Epileptic Portfolio from Desitin Arzneimittel GmbH
June 30, 2004	BurnsAdler Pharmaceuticals, Inc. Licenses NeoVisc® from Stellar Pharmaceuticals, Inc.
June 17, 2003	BurnsAdler Pharmaceuticals, Inc. Licenses Nitrolingual® Pumpspray and Nitronal® IV Infusion from G. Pohl-BoskampGmbH & Co.